AstraZeneca plastic syringes pose potential health risks: Health Canada
- September 28, 2006 10:36 AM
- By Peter Hadzipetros
AstraZeneca Xylocaine 2 % Jelly Single Use Plastic Syringes pose a potential health hazard, Health Canada has advised.
A small plastic fragment at the tip of the syringe may break away and block the needle or enter into the body, the federal agency said in an advisory.
Xylocaine 2% Jelly is used to treat pain caused by inflammation of the urinary tract and bladder. The medical product serves as a surface anesthetic and a lubricator for tests or intubation of the urinary tract, respiratory tract, anal canal and stomach. Health care workers commonly administer the single-use syringes although in some cases the needles can be self-administered by the patient.
The plastic fragments puncturing the body could cause pain, inflammation of the urinary tract, urinary bladder stones, nasal discharge, coughing or respiratory infections. There is also a small risk of perforation of the intestine.
Consumers should stop using the product and return it to point of purchase. They should also contact a health care professional with any questions or concerns.
Consumers requiring more information can contact Health Canada's public inquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
- Seymour Custom Solvent recalled over labelling
- Health Canada has recalled 16,000 Seymour Custom Solvent Blend and Water Blend aerosol products because they do not meet mandatory warning labelling requirements.... Continue reading this post
- Kids eyeglass cases recalled because of lead levels
- About 1,500 childrens' eyeglass cases have been recalled because paint on the cases contains lead levels in excess of federal standards.... Continue reading this post